Search details
1.
Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study.
Lancet Oncol
; 15(13): 1521-1532, 2014 Dec.
Article
in English
| MEDLINE | ID: mdl-25456371
2.
A tiling resolution DNA microarray with complete coverage of the human genome.
Nat Genet
; 36(3): 299-303, 2004 Mar.
Article
in English
| MEDLINE | ID: mdl-14981516
3.
Copy number alterations of c-MYC and PTEN are prognostic factors for relapse after prostate cancer radiotherapy.
Cancer
; 118(16): 4053-62, 2012 Aug 15.
Article
in English
| MEDLINE | ID: mdl-22281794
4.
Array CGH as a potential predictor of radiocurability in intermediate risk prostate cancer.
Acta Oncol
; 49(7): 888-94, 2010 Oct.
Article
in English
| MEDLINE | ID: mdl-20590366
5.
High-resolution array CGH identifies novel regions of genomic alteration in intermediate-risk prostate cancer.
Prostate
; 69(10): 1091-100, 2009 Jul 01.
Article
in English
| MEDLINE | ID: mdl-19350549
6.
Methods for high throughput validation of amplified fragment pools of BAC DNA for constructing high resolution CGH arrays.
BMC Genomics
; 5(1): 6, 2004 Jan 14.
Article
in English
| MEDLINE | ID: mdl-14723794
7.
NKX3.1 haploinsufficiency is prognostic for prostate cancer relapse following surgery or image-guided radiotherapy.
Clin Cancer Res
; 18(1): 308-16, 2012 Jan 01.
Article
in English
| MEDLINE | ID: mdl-22048240
Results
1 -
7
de 7
1
Next >
>>